🔎 Trials Near Me

Hjem › Nyrekreft › California

Kliniske studier for Nyrekreft i California

19 studier for Nyrekreft søker deltakere på steder i California.

Byer i California

Offisiell studietekst (engelsk)

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • og 10 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • University of California San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06234605

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  • University of California Irvine, Orange
  • Stanford, Palo Alto
  • University of California San Francisco, San Francisco
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05287945

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

  • Research Site, Duarte
  • Research Site, Irvine
  • Research Site, La Jolla
  • og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07011719

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04981119

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
  • City of Hope Investigational Drug Services (IDS), Duarte
  • UC San Diego Medical Center - Encinitas, Encinitas
  • og 13 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07227415

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, San Diego
  • Research Site, Santa Monica
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

  • NEO-811 Los Angeles Site, Duarte
  • NEO-811 San Diego Site, San Diego
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07300241

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Duarte
  • Xencor Investigative Site, Sacramento
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT05433142

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT06580002

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA Department of Medicine, Los Angeles
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jun. 2026 · NCT06026410

A Study of VET3-TGI in Patients With Solid Tumors

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • UC Irvine Health, Orange
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 7. apr. 2026 · NCT06444815

64Cu-GRIP B in Patients With Advanced Malignancies

  • University of California, San Francisco, San Francisco
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT05888532

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology

  • VA Palo Alto Healthcare System, Palo Alto
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. des. 2025 · NCT07303725

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • og 3 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  • UCSD Moores Cancer Center, La Jolla
  • UCLA Medical Center, Los Angeles
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT06682793

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jun. 2025 · NCT03175224

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

  • Institute of Urology, University of Southern California., Los Angeles
  • University of California San Diego, Moores Cancer Center, San Diego
  • Stanford University, Stanford
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2022 · NCT05363657

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.